Atlas Trials

Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)

Clinical trial NCT03342690 · COMPLETED

Trial details

NCT number
NCT03342690
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Heart Failure
Start date
2017-07-05
Primary completion
2020-07-15
Enrollment
1165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.